# Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months

> **NCT03909074** · PHASE3 · COMPLETED · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 900 (actual)

## Conditions studied

- Hand, Foot and Mouth Disease

## Interventions

- **BIOLOGICAL:** 36-71 months old children-experimental EV71 vaccine.
- **BIOLOGICAL:** 36-71 months old children-control EV71 vaccine.
- **BIOLOGICAL:** 6-35 months old children-experimental EV71 vaccine.

## Key facts

- **NCT ID:** NCT03909074
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-10
- **Primary completion:** 2019-06-17
- **Final completion:** 2019-11-13
- **Target enrollment:** 900 (ACTUAL)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909074, "Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03909074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*